INSTITUTION'S PROFILE

myDNA Life Australia Limited, South Yarra, VIC, Australia.

Publications (1)

Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.

Journal: The pharmacogenomics journal

Publication date: 2021

Journal: The pharmacogenomics journal

Publication Year: 2021

Authors & Co-authors:  Lesche Dorothea D Mostafa Sam S Everall Ian I Pantelis Christos C Bousman Chad A CA